Figure 2From: Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug developmentSchematic drawing of changes in pathological and functional imaging markers during progression of Alzheimer's disease. Aβ, amyloid beta; AD, Alzheimer's disease; CSF, cerebrospinal fluid; MCI, mild cognitive impairment.Back to article page